NYSE:IMS

IMS Health (IMS) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$31.34
$31.34
50-Day Range
N/A
52-Week Range
$22.36
$31.59
Volume
N/A
Average Volume
1.27 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
IMS stock logo

About IMS Health Stock (NYSE:IMS)

IMS Health Holdings, Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company's data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community. The Company's principal information offerings include national information offerings, sub-national information offerings and OneKey. Its technology services offerings include technology solutions, real-world evidence solutions, and workflow analytics and consulting services. It offers technology services that include data warehousing, information technology (IT) outsourcing, software applications and other services.

IMS Stock News Headlines

Ecolomondo Releases 2023 Annual Results
The AI Stock that’s Disrupting Every Industry
Move over Nvidia. There’s a new hot AI play that has soared 960% in the past year. One high-flying artificial intelligence stock has soared 960% over the past year and may soon become as familiar as Nvidia…
The AI Stock that’s Disrupting Every Industry
Move over Nvidia. There’s a new hot AI play that has soared 960% in the past year. One high-flying artificial intelligence stock has soared 960% over the past year and may soon become as familiar as Nvidia…
Axxela gets ISO recertification
See More Headlines
Receive IMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMS Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/27/2016
Today
5/03/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

IMS Stock Analysis - Frequently Asked Questions

How were IMS Health's earnings last quarter?

IMS Health Holdings Inc (NYSE:IMS) announced its quarterly earnings results on Wednesday, July, 27th. The information technology services provider reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.03. The information technology services provider had revenue of $802 million for the quarter, compared to analyst estimates of $796.93 million. The firm's quarterly revenue was up 112.4% on a year-over-year basis. During the same quarter last year, the company posted $0.37 earnings per share.

What other stocks do shareholders of IMS Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IMS Health investors own include Frontier Communications (FTR), Cognizant Technology Solutions (CTSH), Dollar Tree (DLTR), Oxford Immunotec Global (OXFD), Exact Sciences (EXAS), Ford Motor (F), Hertz Global (HTZ), Incyte (INCY), IQVIA (IQV) and

This page (NYSE:IMS) was last updated on 5/3/2024 by MarketBeat.com Staff

From Our Partners